カテゴリ： Market Monitor Global, 世界, 医療/バイオ

心房細動治療装置のグローバル市場展望 2023年-2029年：カテーテルアブレーション、メイズ手術

■ 英語タイトル：Atrial Fibrillation Therapy Device Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC12601）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC12601
■ 発行日：2023年12月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療機器＆消耗品
■ ページ数：70
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥468,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥608,400見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥702,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[心房細動治療装置のグローバル市場展望 2023年-2029年：カテーテルアブレーション、メイズ手術]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の心房細動治療装置市場規模と予測を収録しています。・世界の心房細動治療装置市場：売上、2018年-2023年、2024年-2029年
・世界の心房細動治療装置市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の心房細動治療装置市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「カテーテルアブレーション」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

心房細動治療装置のグローバル主要企業は、Johnson & Johnson、 Abbott、 Medtronic、 Japan Lifeline、 Boston Scientific、 Atricure、 Biotroik、 OSYPKA、 Cardiofocus、 MicroPort EP MedTech、 Synaptic Medicalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、心房細動治療装置のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の心房細動治療装置市場：タイプ別、2018年-2023年、2024年-2029年
世界の心房細動治療装置市場：タイプ別市場シェア、2022年
・カテーテルアブレーション、メイズ手術

世界の心房細動治療装置市場：用途別、2018年-2023年、2024年-2029年
世界の心房細動治療装置市場：用途別市場シェア、2022年
・病院、外来手術センター、その他

世界の心房細動治療装置市場：地域・国別、2018年-2023年、2024年-2029年
世界の心房細動治療装置市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における心房細動治療装置のグローバル売上、2018年-2023年
・主要企業における心房細動治療装置のグローバル売上シェア、2022年
・主要企業における心房細動治療装置のグローバル販売量、2018年-2023年
・主要企業における心房細動治療装置のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Johnson & Johnson、 Abbott、 Medtronic、 Japan Lifeline、 Boston Scientific、 Atricure、 Biotroik、 OSYPKA、 Cardiofocus、 MicroPort EP MedTech、 Synaptic Medical

*************************************************************

・調査・分析レポートの概要
心房細動治療装置市場の定義
市場セグメント
世界の心房細動治療装置市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の心房細動治療装置市場規模
世界の心房細動治療装置市場規模：2022年 VS 2029年
世界の心房細動治療装置市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの心房細動治療装置の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の心房細動治療装置製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：カテーテルアブレーション、メイズ手術
心房細動治療装置のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、外来手術センター、その他
心房細動治療装置の用途別グローバル売上・予測

・地域別市場分析
地域別心房細動治療装置市場規模 2022年と2029年
地域別心房細動治療装置売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Johnson & Johnson、 Abbott、 Medtronic、 Japan Lifeline、 Boston Scientific、 Atricure、 Biotroik、 OSYPKA、 Cardiofocus、 MicroPort EP MedTech、 Synaptic Medical
...

This research report provides a comprehensive analysis of the Atrial Fibrillation Therapy Device market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Atrial Fibrillation Therapy Device market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Atrial Fibrillation Therapy Device, challenges faced by the industry, and potential opportunities for market players.
The global Atrial Fibrillation Therapy Device market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Atrial Fibrillation Therapy Device market presents opportunities for various stakeholders, including Hospitals, Ambulatory Surgical Centers. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Atrial Fibrillation Therapy Device market. Additionally, the growing consumer demand present avenues for market expansion.
The global Atrial Fibrillation Therapy Device market was valued at US$ 3052.5 million in 2022 and is projected to reach US$ 6418.7 million by 2029, at a CAGR of 11.4% during the forecast period.
The Atrial Fibrillation Therapy Device Market is driven by the rising prevalence of atrial fibrillation and the need for effective treatment options. These devices, including implantable pacemakers and ablation devices, offer solutions to manage irregular heart rhythms. However, a significant challenge is the need for constant innovation and advanced technologies to improve the efficacy of atrial fibrillation therapies. Regulatory approvals and ensuring patient safety pose challenges for manufacturers. Additionally, market competition and cost considerations necessitate a balance between affordability and cutting-edge technology to meet the evolving needs of patients and healthcare providers while ensuring the best possible outcomes in the management of atrial fibrillation.
Key Features:
The research report on the Atrial Fibrillation Therapy Device market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Atrial Fibrillation Therapy Device market.
Market Overview: The report provides a comprehensive overview of the Atrial Fibrillation Therapy Device market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Catheter Ablation, Maze Surgery), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Atrial Fibrillation Therapy Device market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Atrial Fibrillation Therapy Device market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Atrial Fibrillation Therapy Device market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Atrial Fibrillation Therapy Device market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Atrial Fibrillation Therapy Device market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Atrial Fibrillation Therapy Device market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Atrial Fibrillation Therapy Device, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Atrial Fibrillation Therapy Device market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Atrial Fibrillation Therapy Device market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Catheter Ablation
Maze Surgery
Market segment by Application
Hospitals
Ambulatory Surgical Centers
Other
Global Atrial Fibrillation Therapy Device Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Johnson & Johnson
Abbott
Medtronic
Japan Lifeline
Boston Scientific
Atricure
Biotroik
OSYPKA
Cardiofocus
MicroPort EP MedTech
Synaptic Medical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Atrial Fibrillation Therapy Device, market overview.
Chapter 2: Global Atrial Fibrillation Therapy Device market size in revenue and volume.
Chapter 3: Detailed analysis of Atrial Fibrillation Therapy Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Atrial Fibrillation Therapy Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Atrial Fibrillation Therapy Device capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Atrial Fibrillation Therapy Device Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Atrial Fibrillation Therapy Device Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Atrial Fibrillation Therapy Device Overall Market Size
2.1 Global Atrial Fibrillation Therapy Device Market Size: 2022 VS 2029
2.2 Global Atrial Fibrillation Therapy Device Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Atrial Fibrillation Therapy Device Sales: 2018-2029
3 Company Landscape
3.1 Top Atrial Fibrillation Therapy Device Players in Global Market
3.2 Top Global Atrial Fibrillation Therapy Device Companies Ranked by Revenue
3.3 Global Atrial Fibrillation Therapy Device Revenue by Companies
3.4 Global Atrial Fibrillation Therapy Device Sales by Companies
3.5 Global Atrial Fibrillation Therapy Device Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Atrial Fibrillation Therapy Device Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Atrial Fibrillation Therapy Device Product Type
3.8 Tier 1, Tier 2 and Tier 3 Atrial Fibrillation Therapy Device Players in Global Market
3.8.1 List of Global Tier 1 Atrial Fibrillation Therapy Device Companies
3.8.2 List of Global Tier 2 and Tier 3 Atrial Fibrillation Therapy Device Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Atrial Fibrillation Therapy Device Market Size Markets, 2022 & 2029
4.1.2 Catheter Ablation
4.1.3 Maze Surgery
4.2 By Type – Global Atrial Fibrillation Therapy Device Revenue & Forecasts
4.2.1 By Type – Global Atrial Fibrillation Therapy Device Revenue, 2018-2023
4.2.2 By Type – Global Atrial Fibrillation Therapy Device Revenue, 2024-2029
4.2.3 By Type – Global Atrial Fibrillation Therapy Device Revenue Market Share, 2018-2029
4.3 By Type – Global Atrial Fibrillation Therapy Device Sales & Forecasts
4.3.1 By Type – Global Atrial Fibrillation Therapy Device Sales, 2018-2023
4.3.2 By Type – Global Atrial Fibrillation Therapy Device Sales, 2024-2029
4.3.3 By Type – Global Atrial Fibrillation Therapy Device Sales Market Share, 2018-2029
4.4 By Type – Global Atrial Fibrillation Therapy Device Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Atrial Fibrillation Therapy Device Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Other
5.2 By Application – Global Atrial Fibrillation Therapy Device Revenue & Forecasts
5.2.1 By Application – Global Atrial Fibrillation Therapy Device Revenue, 2018-2023
5.2.2 By Application – Global Atrial Fibrillation Therapy Device Revenue, 2024-2029
5.2.3 By Application – Global Atrial Fibrillation Therapy Device Revenue Market Share, 2018-2029
5.3 By Application – Global Atrial Fibrillation Therapy Device Sales & Forecasts
5.3.1 By Application – Global Atrial Fibrillation Therapy Device Sales, 2018-2023
5.3.2 By Application – Global Atrial Fibrillation Therapy Device Sales, 2024-2029
5.3.3 By Application – Global Atrial Fibrillation Therapy Device Sales Market Share, 2018-2029
5.4 By Application – Global Atrial Fibrillation Therapy Device Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Atrial Fibrillation Therapy Device Market Size, 2022 & 2029
6.2 By Region – Global Atrial Fibrillation Therapy Device Revenue & Forecasts
6.2.1 By Region – Global Atrial Fibrillation Therapy Device Revenue, 2018-2023
6.2.2 By Region – Global Atrial Fibrillation Therapy Device Revenue, 2024-2029
6.2.3 By Region – Global Atrial Fibrillation Therapy Device Revenue Market Share, 2018-2029
6.3 By Region – Global Atrial Fibrillation Therapy Device Sales & Forecasts
6.3.1 By Region – Global Atrial Fibrillation Therapy Device Sales, 2018-2023
6.3.2 By Region – Global Atrial Fibrillation Therapy Device Sales, 2024-2029
6.3.3 By Region – Global Atrial Fibrillation Therapy Device Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Atrial Fibrillation Therapy Device Revenue, 2018-2029
6.4.2 By Country – North America Atrial Fibrillation Therapy Device Sales, 2018-2029
6.4.3 US Atrial Fibrillation Therapy Device Market Size, 2018-2029
6.4.4 Canada Atrial Fibrillation Therapy Device Market Size, 2018-2029
6.4.5 Mexico Atrial Fibrillation Therapy Device Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Atrial Fibrillation Therapy Device Revenue, 2018-2029
6.5.2 By Country – Europe Atrial Fibrillation Therapy Device Sales, 2018-2029
6.5.3 Germany Atrial Fibrillation Therapy Device Market Size, 2018-2029
6.5.4 France Atrial Fibrillation Therapy Device Market Size, 2018-2029
6.5.5 U.K. Atrial Fibrillation Therapy Device Market Size, 2018-2029
6.5.6 Italy Atrial Fibrillation Therapy Device Market Size, 2018-2029
6.5.7 Russia Atrial Fibrillation Therapy Device Market Size, 2018-2029
6.5.8 Nordic Countries Atrial Fibrillation Therapy Device Market Size, 2018-2029
6.5.9 Benelux Atrial Fibrillation Therapy Device Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Atrial Fibrillation Therapy Device Revenue, 2018-2029
6.6.2 By Region – Asia Atrial Fibrillation Therapy Device Sales, 2018-2029
6.6.3 China Atrial Fibrillation Therapy Device Market Size, 2018-2029
6.6.4 Japan Atrial Fibrillation Therapy Device Market Size, 2018-2029
6.6.5 South Korea Atrial Fibrillation Therapy Device Market Size, 2018-2029
6.6.6 Southeast Asia Atrial Fibrillation Therapy Device Market Size, 2018-2029
6.6.7 India Atrial Fibrillation Therapy Device Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Atrial Fibrillation Therapy Device Revenue, 2018-2029
6.7.2 By Country – South America Atrial Fibrillation Therapy Device Sales, 2018-2029
6.7.3 Brazil Atrial Fibrillation Therapy Device Market Size, 2018-2029
6.7.4 Argentina Atrial Fibrillation Therapy Device Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Atrial Fibrillation Therapy Device Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Atrial Fibrillation Therapy Device Sales, 2018-2029
6.8.3 Turkey Atrial Fibrillation Therapy Device Market Size, 2018-2029
6.8.4 Israel Atrial Fibrillation Therapy Device Market Size, 2018-2029
6.8.5 Saudi Arabia Atrial Fibrillation Therapy Device Market Size, 2018-2029
6.8.6 UAE Atrial Fibrillation Therapy Device Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Atrial Fibrillation Therapy Device Major Product Offerings
7.1.4 Johnson & Johnson Atrial Fibrillation Therapy Device Sales and Revenue in Global (2018-2023)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Abbott
7.2.1 Abbott Company Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Atrial Fibrillation Therapy Device Major Product Offerings
7.2.4 Abbott Atrial Fibrillation Therapy Device Sales and Revenue in Global (2018-2023)
7.2.5 Abbott Key News & Latest Developments
7.3 Medtronic
7.3.1 Medtronic Company Summary
7.3.2 Medtronic Business Overview
7.3.3 Medtronic Atrial Fibrillation Therapy Device Major Product Offerings
7.3.4 Medtronic Atrial Fibrillation Therapy Device Sales and Revenue in Global (2018-2023)
7.3.5 Medtronic Key News & Latest Developments
7.4 Japan Lifeline
7.4.1 Japan Lifeline Company Summary
7.4.2 Japan Lifeline Business Overview
7.4.3 Japan Lifeline Atrial Fibrillation Therapy Device Major Product Offerings
7.4.4 Japan Lifeline Atrial Fibrillation Therapy Device Sales and Revenue in Global (2018-2023)
7.4.5 Japan Lifeline Key News & Latest Developments
7.5 Boston Scientific
7.5.1 Boston Scientific Company Summary
7.5.2 Boston Scientific Business Overview
7.5.3 Boston Scientific Atrial Fibrillation Therapy Device Major Product Offerings
7.5.4 Boston Scientific Atrial Fibrillation Therapy Device Sales and Revenue in Global (2018-2023)
7.5.5 Boston Scientific Key News & Latest Developments
7.6 Atricure
7.6.1 Atricure Company Summary
7.6.2 Atricure Business Overview
7.6.3 Atricure Atrial Fibrillation Therapy Device Major Product Offerings
7.6.4 Atricure Atrial Fibrillation Therapy Device Sales and Revenue in Global (2018-2023)
7.6.5 Atricure Key News & Latest Developments
7.7 Biotroik
7.7.1 Biotroik Company Summary
7.7.2 Biotroik Business Overview
7.7.3 Biotroik Atrial Fibrillation Therapy Device Major Product Offerings
7.7.4 Biotroik Atrial Fibrillation Therapy Device Sales and Revenue in Global (2018-2023)
7.7.5 Biotroik Key News & Latest Developments
7.8 OSYPKA
7.8.1 OSYPKA Company Summary
7.8.2 OSYPKA Business Overview
7.8.3 OSYPKA Atrial Fibrillation Therapy Device Major Product Offerings
7.8.4 OSYPKA Atrial Fibrillation Therapy Device Sales and Revenue in Global (2018-2023)
7.8.5 OSYPKA Key News & Latest Developments
7.9 Cardiofocus
7.9.1 Cardiofocus Company Summary
7.9.2 Cardiofocus Business Overview
7.9.3 Cardiofocus Atrial Fibrillation Therapy Device Major Product Offerings
7.9.4 Cardiofocus Atrial Fibrillation Therapy Device Sales and Revenue in Global (2018-2023)
7.9.5 Cardiofocus Key News & Latest Developments
7.10 MicroPort EP MedTech
7.10.1 MicroPort EP MedTech Company Summary
7.10.2 MicroPort EP MedTech Business Overview
7.10.3 MicroPort EP MedTech Atrial Fibrillation Therapy Device Major Product Offerings
7.10.4 MicroPort EP MedTech Atrial Fibrillation Therapy Device Sales and Revenue in Global (2018-2023)
7.10.5 MicroPort EP MedTech Key News & Latest Developments
7.11 Synaptic Medical
7.11.1 Synaptic Medical Company Summary
7.11.2 Synaptic Medical Business Overview
7.11.3 Synaptic Medical Atrial Fibrillation Therapy Device Major Product Offerings
7.11.4 Synaptic Medical Atrial Fibrillation Therapy Device Sales and Revenue in Global (2018-2023)
7.11.5 Synaptic Medical Key News & Latest Developments
8 Global Atrial Fibrillation Therapy Device Production Capacity, Analysis
8.1 Global Atrial Fibrillation Therapy Device Production Capacity, 2018-2029
8.2 Atrial Fibrillation Therapy Device Production Capacity of Key Manufacturers in Global Market
8.3 Global Atrial Fibrillation Therapy Device Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Atrial Fibrillation Therapy Device Supply Chain Analysis
10.1 Atrial Fibrillation Therapy Device Industry Value Chain
10.2 Atrial Fibrillation Therapy Device Upstream Market
10.3 Atrial Fibrillation Therapy Device Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Atrial Fibrillation Therapy Device Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Atrial Fibrillation Therapy Device in Global Market
Table 2. Top Atrial Fibrillation Therapy Device Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Atrial Fibrillation Therapy Device Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Atrial Fibrillation Therapy Device Revenue Share by Companies, 2018-2023
Table 5. Global Atrial Fibrillation Therapy Device Sales by Companies, (K Units), 2018-2023
Table 6. Global Atrial Fibrillation Therapy Device Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Atrial Fibrillation Therapy Device Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Atrial Fibrillation Therapy Device Product Type
Table 9. List of Global Tier 1 Atrial Fibrillation Therapy Device Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Atrial Fibrillation Therapy Device Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Atrial Fibrillation Therapy Device Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Atrial Fibrillation Therapy Device Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Atrial Fibrillation Therapy Device Sales (K Units), 2018-2023
Table 15. By Type - Global Atrial Fibrillation Therapy Device Sales (K Units), 2024-2029
Table 16. By Application – Global Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Atrial Fibrillation Therapy Device Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Atrial Fibrillation Therapy Device Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Atrial Fibrillation Therapy Device Sales (K Units), 2018-2023
Table 20. By Application - Global Atrial Fibrillation Therapy Device Sales (K Units), 2024-2029
Table 21. By Region – Global Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Atrial Fibrillation Therapy Device Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Atrial Fibrillation Therapy Device Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Atrial Fibrillation Therapy Device Sales (K Units), 2018-2023
Table 25. By Region - Global Atrial Fibrillation Therapy Device Sales (K Units), 2024-2029
Table 26. By Country - North America Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Atrial Fibrillation Therapy Device Sales, (K Units), 2018-2023
Table 29. By Country - North America Atrial Fibrillation Therapy Device Sales, (K Units), 2024-2029
Table 30. By Country - Europe Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Atrial Fibrillation Therapy Device Sales, (K Units), 2018-2023
Table 33. By Country - Europe Atrial Fibrillation Therapy Device Sales, (K Units), 2024-2029
Table 34. By Region - Asia Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Atrial Fibrillation Therapy Device Sales, (K Units), 2018-2023
Table 37. By Region - Asia Atrial Fibrillation Therapy Device Sales, (K Units), 2024-2029
Table 38. By Country - South America Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Atrial Fibrillation Therapy Device Sales, (K Units), 2018-2023
Table 41. By Country - South America Atrial Fibrillation Therapy Device Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Atrial Fibrillation Therapy Device Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Atrial Fibrillation Therapy Device Sales, (K Units), 2024-2029
Table 46. Johnson & Johnson Company Summary
Table 47. Johnson & Johnson Atrial Fibrillation Therapy Device Product Offerings
Table 48. Johnson & Johnson Atrial Fibrillation Therapy Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Abbott Company Summary
Table 51. Abbott Atrial Fibrillation Therapy Device Product Offerings
Table 52. Abbott Atrial Fibrillation Therapy Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Abbott Key News & Latest Developments
Table 54. Medtronic Company Summary
Table 55. Medtronic Atrial Fibrillation Therapy Device Product Offerings
Table 56. Medtronic Atrial Fibrillation Therapy Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Medtronic Key News & Latest Developments
Table 58. Japan Lifeline Company Summary
Table 59. Japan Lifeline Atrial Fibrillation Therapy Device Product Offerings
Table 60. Japan Lifeline Atrial Fibrillation Therapy Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Japan Lifeline Key News & Latest Developments
Table 62. Boston Scientific Company Summary
Table 63. Boston Scientific Atrial Fibrillation Therapy Device Product Offerings
Table 64. Boston Scientific Atrial Fibrillation Therapy Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Boston Scientific Key News & Latest Developments
Table 66. Atricure Company Summary
Table 67. Atricure Atrial Fibrillation Therapy Device Product Offerings
Table 68. Atricure Atrial Fibrillation Therapy Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Atricure Key News & Latest Developments
Table 70. Biotroik Company Summary
Table 71. Biotroik Atrial Fibrillation Therapy Device Product Offerings
Table 72. Biotroik Atrial Fibrillation Therapy Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Biotroik Key News & Latest Developments
Table 74. OSYPKA Company Summary
Table 75. OSYPKA Atrial Fibrillation Therapy Device Product Offerings
Table 76. OSYPKA Atrial Fibrillation Therapy Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. OSYPKA Key News & Latest Developments
Table 78. Cardiofocus Company Summary
Table 79. Cardiofocus Atrial Fibrillation Therapy Device Product Offerings
Table 80. Cardiofocus Atrial Fibrillation Therapy Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Cardiofocus Key News & Latest Developments
Table 82. MicroPort EP MedTech Company Summary
Table 83. MicroPort EP MedTech Atrial Fibrillation Therapy Device Product Offerings
Table 84. MicroPort EP MedTech Atrial Fibrillation Therapy Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. MicroPort EP MedTech Key News & Latest Developments
Table 86. Synaptic Medical Company Summary
Table 87. Synaptic Medical Atrial Fibrillation Therapy Device Product Offerings
Table 88. Synaptic Medical Atrial Fibrillation Therapy Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Synaptic Medical Key News & Latest Developments
Table 90. Atrial Fibrillation Therapy Device Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 91. Global Atrial Fibrillation Therapy Device Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global Atrial Fibrillation Therapy Device Production by Region, 2018-2023 (K Units)
Table 93. Global Atrial Fibrillation Therapy Device Production by Region, 2024-2029 (K Units)
Table 94. Atrial Fibrillation Therapy Device Market Opportunities & Trends in Global Market
Table 95. Atrial Fibrillation Therapy Device Market Drivers in Global Market
Table 96. Atrial Fibrillation Therapy Device Market Restraints in Global Market
Table 97. Atrial Fibrillation Therapy Device Raw Materials
Table 98. Atrial Fibrillation Therapy Device Raw Materials Suppliers in Global Market
Table 99. Typical Atrial Fibrillation Therapy Device Downstream
Table 100. Atrial Fibrillation Therapy Device Downstream Clients in Global Market
Table 101. Atrial Fibrillation Therapy Device Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Atrial Fibrillation Therapy Device Segment by Type in 2022
Figure 2. Atrial Fibrillation Therapy Device Segment by Application in 2022
Figure 3. Global Atrial Fibrillation Therapy Device Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Atrial Fibrillation Therapy Device Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Atrial Fibrillation Therapy Device Revenue, 2018-2029 (US$, Mn)
Figure 7. Atrial Fibrillation Therapy Device Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Atrial Fibrillation Therapy Device Revenue in 2022
Figure 9. By Type - Global Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Atrial Fibrillation Therapy Device Revenue Market Share, 2018-2029
Figure 11. By Type - Global Atrial Fibrillation Therapy Device Sales Market Share, 2018-2029
Figure 12. By Type - Global Atrial Fibrillation Therapy Device Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Atrial Fibrillation Therapy Device Revenue Market Share, 2018-2029
Figure 15. By Application - Global Atrial Fibrillation Therapy Device Sales Market Share, 2018-2029
Figure 16. By Application - Global Atrial Fibrillation Therapy Device Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Atrial Fibrillation Therapy Device Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Atrial Fibrillation Therapy Device Revenue Market Share, 2018-2029
Figure 20. By Region - Global Atrial Fibrillation Therapy Device Sales Market Share, 2018-2029
Figure 21. By Country - North America Atrial Fibrillation Therapy Device Revenue Market Share, 2018-2029
Figure 22. By Country - North America Atrial Fibrillation Therapy Device Sales Market Share, 2018-2029
Figure 23. US Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Atrial Fibrillation Therapy Device Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Atrial Fibrillation Therapy Device Sales Market Share, 2018-2029
Figure 28. Germany Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2018-2029
Figure 29. France Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Atrial Fibrillation Therapy Device Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Atrial Fibrillation Therapy Device Sales Market Share, 2018-2029
Figure 37. China Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2018-2029
Figure 41. India Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Atrial Fibrillation Therapy Device Revenue Market Share, 2018-2029
Figure 43. By Country - South America Atrial Fibrillation Therapy Device Sales Market Share, 2018-2029
Figure 44. Brazil Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Atrial Fibrillation Therapy Device Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Atrial Fibrillation Therapy Device Sales Market Share, 2018-2029
Figure 48. Turkey Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Atrial Fibrillation Therapy Device Revenue, (US$, Mn), 2018-2029
Figure 52. Global Atrial Fibrillation Therapy Device Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Atrial Fibrillation Therapy Device by Region, 2022 VS 2029
Figure 54. Atrial Fibrillation Therapy Device Industry Value Chain
Figure 55. Marketing Channels

※参考情報

心房細動治療装置についての考察を以下に記述いたします。

心房細動とは、心臓の上室（心房）が異常に速く乱れた電気的活動を示す状態であり、その結果として心臓の正常なリズムが失われてしまう病態です。この状態によって、血流が不規則になり、血栓の形成リスクが増加し、ひいては脳梗塞や心不全などの重篤な合併症を引き起こす可能性があります。心房細動は、特に高齢者に多く見られる疾患であり、世界中でその治療法に関心が寄せられています。

心房細動治療装置とは、この心房細動を効果的に管理、治療するための医療機器やデバイスの総称です。これらの装置は、心房細動の発症を予防すること、症状を軽減すること、または心房細動から生じる合併症を防ぐことを目的としています。心房細動治療装置は、主にペースメーカーや植込み型除細動器、カテーテルアブレーション装置などに分類されます。

まずはペースメーカーについて説明します。ペースメーカーは、心臓のリズムを正常に保つために人工的に電気信号を送る装置です。心房細動の患者においては、心房の不整脈によって心拍数が不規則になることが多く、これが症状（動悸や息切れ）を引き起こします。ペースメーカーは、心臓の動きを適切に調整することで、こうした症状を軽減する役割を果たします。また、最近のペースメーカーには、遠隔モニタリング機能が搭載されており、患者の心電図データをリアルタイムで医療機関に送信することが可能になっています。これにより、医師は患者の状態を迅速に把握し、適切な治療を行うことができます。

次に、植込み型除細動器について説明します。このデバイスは、心房細動を伴う危険な不整脈（心室細動など）を検知したときに、電気ショックを用いて心臓の正常なリズムを復元することを目的としています。心房細動は常に生命に危険を及ぼすわけではありませんが、特に心室細動を合併するリスクがある患者には、植込み型除細動器が推奨される場合があります。このデバイスは生命維持に直結するため、精密で信頼性の高い機能が要求されます。

カテーテルアブレーション装置についても触れておきます。カテーテルアブレーションは、心房細動の原因となる異常な電気信号の経路を識別し、そこに高周波エネルギーや冷却エネルギーを用いて治療を行う方法です。この手技により、心房細動の根治を目指すことができます。カテーテルアブレーションは、特に薬物療法が効果を示さない場合や、側面的な治療として行われることが多いです。アブレーションの成功率は高いものの、施術に対するリスクも伴うため、患者の状態に応じた適切な判断が求められます。

心房細動治療に関連する技術として、心電図のデジタル化や解析技術が重要です。最新の心電図解析ソフトウェアは、心房細動のパターンを迅速に識別し、医師の診断を支援します。これにより、早期発見や治療方針の決定が円滑に行えるようになります。また、ウェアラブルデバイスの進化も見逃せません。心電図をリアルタイムでモニタリングするウェアラブルデバイスが登場し、患者自身が手軽に心臓の健康状態を確認できるようになっています。これにより、患者の治療の自己管理が促進され、心房細動の早期発見につながる可能性があります。

また、テレメディスンも心房細動の管理において重要な役割を果たしています。患者が自宅にいながら医師とオンラインで相談できる環境が整いつつあり、患者に適した治療を提案するための情報を速やかに入手できるようになっています。特に、心房細動の患者は定期的なフォローアップが必要であるため、テレメディスンは大きな利点となります。

治療装置の選択にあたっては、患者の年齢、合併症の有無、心房細動の発症頻度や持続時間など、多くの要因が考慮されます。それぞれの治療法にはメリットとデメリットがあり、医師と患者がしっかりとコミュニケーションを取った上で、最適な治療方針を決定することが重要です。

心房細動に対する治療は、依然として進化し続けています。新たな薬剤の開発、デバイスの改良、治療法の見直しなど、様々なアプローチが行われています。これらの技術の進展は、心房細動を持つ多くの患者にとって、生活の質を向上させ、合併症のリスクを低減させる手助けとなることが期待されています。

今後も心房細動治療装置は、ますます進化し続けるでしょう。その過程においては、患者への負担を軽減し、より効果的な治療を提供するための技術革新が必要不可欠です。医療従事者、研究者、エンジニアの協力によって、心房細動の治療における新しい希望が見出されることを期待しています。このような装置や技術が展開されることで、患者が安心して治療を受けられる未来が訪れることを願ってやみません。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 心室細動用治療のグローバル市場2023：CPR、除細動、投薬、カテーテルアブレーション
  • 糖尿病ポンプ療法のグローバル市場展望 2023年-2029年：チューブタイプ、パッチタイプ
  • 医療用ラジオ波焼灼装置のグローバル市場展望 2023年-2029年：高周波アブレーション心臓治療器、高周波アブレーション前立腺治療器、腫瘍用高周波温熱治療器、その他
  • 医療用オゾン療法装置のグローバル市場展望 2023年-2029年：固定式、移動式
  • 睡眠時無呼吸症候群治療装置のグローバル市場展望 2023年-2029年：CPAP装置、位置治療装置、口腔装置、インプラントシステム
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC12601 )"心房細動治療装置のグローバル市場展望 2023年-2029年：カテーテルアブレーション、メイズ手術" (英文：Atrial Fibrillation Therapy Device Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。